# Bioequivalence Study of Cephalexin Tablets 1g

> **NCT01767584** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26 (actual)

## Conditions studied

- Infections, Respiratory Tract

## Interventions

- **DRUG:** Cephalexin 1g tablets
- **DRUG:** Cephalexin 1g tablets

## Key facts

- **NCT ID:** NCT01767584
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-06
- **Primary completion:** 2009-04-14
- **Final completion:** 2009-04-14
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01767584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01767584, "Bioequivalence Study of Cephalexin Tablets 1g". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01767584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*